Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls
Authors:
- the CommonMind ConsortiumTCthe CommonMind Consortium
- Mads E. HaubergMHMads E. Hauberg
- Lingxue ZhuLZLingxue Zhu
- Jessica S. JohnsonJJJessica S. Johnson
- Minghui WangMWMinghui Wang
- Anders Dupont BørglumABAnders Dupont Børglum
- 8 May 2018
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 24 (11) , 1685-1695
Abstract
Transcription at enhancers is a widespread phenomenon which produces so-called enhancer RNA (eRNA) and occurs in an activity-dependent manner. However, the role of eRNA and its utility in exploring disease-associated changes in enhancer function, and the downstream coding transcripts that they regulate, is not well established. We used transcriptomic and epigenomic data to interrogate the relationship of eRNA transcription to disease status and how genetic variants alter enhancer transcriptional activity in the human brain. We combined RNA-seq data from 537 postmortem brain samples from the CommonMind Consortium with cap analysis of gene expression and enhancer identification, using the assay for transposase-accessible chromatin followed by sequencing (ATACseq). We find 118 differentially transcribed eRNAs in schizophrenia and identify schizophrenia-associated gene/eRNA co-expression modules. Perturbations of a key module are associated with the polygenic risk scores. Furthermore, we identify genetic variants affecting expression of 927 enhancers, which we refer to as enhancer expression quantitative loci or eeQTLs. Enhancer expression patterns are consistent across studies, including differentially expressed eRNAs and eeQTLs. Combining eeQTLs with a genome-wide association study of schizophrenia identifies a genetic variant that alters enhancer function and expression of its target gene, GOLPH3L. Our novel approach to analyzing enhancer transcription is adaptable to other large-scale, non-poly-A depleted, RNA-seq studies.Keywords
This publication has 32 references indexed in Scilit:
- Gene expression elucidates functional impact of polygenic risk for schizophreniaNature Neuroscience, 2016
- Systematically characterizing dysfunctional long intergenic non-coding RNAs in multiple brain regions of major psychosisOncotarget, 2016
- Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk VariantsJAMA Psychiatry, 2016
- Enhancers as non-coding RNA transcription units: recent insights and future perspectivesNature Reviews Genetics, 2016
- Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cellsScience, 2015
- A Role for Noncoding Variation in SchizophreniaCell Reports, 2014
- An atlas of active enhancers across human cell types and tissuesNature, 2014
- A System-Level Transcriptomic Analysis of Schizophrenia Using Postmortem Brain Tissue SamplesArchives of General Psychiatry, 2012
- Neuroanatomical abnormalities in schizophrenia: A multimodal voxelwise meta-analysis and meta-regression analysisSchizophrenia Research, 2011
- Widespread transcription at neuronal activity-regulated enhancersNature, 2010